Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia
- 1 February 1999
- Vol. 53 (2) , 329-335
- https://doi.org/10.1016/s0090-4295(98)00506-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension StudyArchives of internal medicine (1960), 1996
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- 29-Week Doxazosin Treatment in Patients with Symptomatic Benign Prostatic HyperplasiaScandinavian Journal of Urology and Nephrology, 1994
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- DoxazosinDrugs, 1988
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- The pharmacokinetics of doxazosin in elderly normotensives.British Journal of Clinical Pharmacology, 1986
- A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- The metabolism and kinetics of doxazosin in man, mouse, rat and dog.British Journal of Clinical Pharmacology, 1986